Loading insider details...
Beta
Latest Form 4 (May 4, 2026): Grant/Award of 25,344 EBS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 4, 2026 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 25,344 | n/a |
| Feb 6, 2026 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 24,000 | n/a |
| Jan 16, 2026 | Eledon Pharmaceuticals, Inc. (ELDN) | Exercise/Conversion | 8,575 | n/a |
| May 28, 2025 | Emergent BioSolutions Inc. (EBS) | Sale | 7,844 | $49.4K |
| May 19, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Purchase | 10,000 | $91.1K |
| May 3, 2025 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 34,403 | n/a |
| Feb 7, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 25,000 | n/a |
| Jan 13, 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 77,175 | n/a |
| May 29, 2024 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 17,430 | n/a |
| Feb 9, 2024 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 17,000 | n/a |